BSAC Vanguard Series: From treatment options to precision medicine: the future of ‘omics-based’ antibiotic resistance surveillance data | Zendy

Sabiha Y. Essack | Zendy

Open Access

BSAC Vanguard Series: From treatment options to precision medicine: the future of ‘omics-based’ antibiotic resistance surveillance data

Author(s) -

Sabiha Y. Essack

Publication year - 2021

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkab417

Subject(s) - precision medicine , metagenomics , antibiotic resistance , vanguard , antibiotics , computational biology , medicine , bioinformatics , biology , microbiology and biotechnology , genetics , gene , pathology , geography , archaeology

Conventional culture-based phenotypic and genomic surveillance has drawbacks and may not necessarily reflect the true burden of antibiotic resistance. The integration of metagenomic surveillance with transcriptomics and proteomics will yield a step change in the utility of surveillance data from treatment options to precision medicine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research